Crake Asset Management LLP Purchases 44,087 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Crake Asset Management LLP grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 176.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,087 shares of the company's stock after buying an additional 44,087 shares during the quarter. HCA Healthcare makes up about 2.2% of Crake Asset Management LLP's investment portfolio, making the stock its 6th biggest position. Crake Asset Management LLP's holdings in HCA Healthcare were worth $20,736,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Galvin Gaustad & Stein LLC bought a new position in HCA Healthcare in the fourth quarter valued at about $18,044,000. NRI Wealth Management LC bought a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $2,896,000. Czech National Bank boosted its stake in HCA Healthcare by 4.5% in the fourth quarter. Czech National Bank now owns 39,543 shares of the company's stock valued at $11,869,000 after acquiring an additional 1,691 shares during the last quarter. Peak Financial Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $1,122,000. Finally, Wedge Capital Management L L P NC boosted its stake in HCA Healthcare by 7.7% during the 4th quarter. Wedge Capital Management L L P NC now owns 116,075 shares of the company's stock worth $34,840,000 after acquiring an additional 8,329 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HCA. Bank of America reduced their target price on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a report on Monday, January 27th. StockNews.com cut shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Wednesday, April 9th. Royal Bank of Canada cut their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research note on Monday, January 27th. Guggenheim began coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Finally, Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $381.67.

Insiders Place Their Bets

In related news, SVP Jennifer Berres sold 9,533 shares of the firm's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.30% of the company's stock.

HCA Healthcare Trading Up 2.2 %

Shares of NYSE:HCA opened at $324.64 on Wednesday. The company has a market capitalization of $79.93 billion, a P/E ratio of 14.78, a P/E/G ratio of 1.10 and a beta of 1.48. The business's 50 day simple moving average is $328.71 and its 200 day simple moving average is $333.13. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the firm posted $5.90 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were issued a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, March 17th. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.89%. HCA Healthcare's dividend payout ratio is 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.